Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Wednesday, November 11, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
Authors
Posts by Ogkologos
Ogkologos
4396 POSTS
0 COMMENTS
Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients...
Ogkologos
-
December 2, 2024
0
Contact X-ray Brachytherapy Dose Escalation Increases the Organ Preservation Rate in...
Ogkologos
-
November 29, 2024
0
Inavolisib Plus Palbociclib–Fulvestrant Prolongs PFS in Patients with PIK3CA-mutated, HR-positive, HER2-negative...
Ogkologos
-
November 28, 2024
0
ESMO Asia Congress 2024, Singapore, 6-8 December
Ogkologos
-
November 27, 2024
0
EMA Recommends Granting a Conditional Marketing Authorisation for Repotrectinib
Ogkologos
-
November 27, 2024
0
FDA Grants Accelerated Approval to Asciminib for Newly Diagnosed Chronic Myeloid...
Ogkologos
-
November 26, 2024
0
Adding Pembrolizumab to Chemotherapy Results in Improved PFS and OS in...
Ogkologos
-
November 25, 2024
0
Neoadjuvant Nivolumab/Relatlimab Induces High Rates of Pathologic Responses in Patients with...
Ogkologos
-
November 22, 2024
0
Trial Results Support SBRT as a Standard Option for Some Prostate...
Ogkologos
-
November 21, 2024
0
Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage...
Ogkologos
-
November 21, 2024
0
1
...
63
64
65
...
440
Page 64 of 440
MOST POPULAR
Perioperative Durvalumab Plus Neoadjuvant Chemotherapy Improves EFS and OS in Cisplatin-Eligible...
November 18, 2024
How I Learned to Cope With Survivor’s Guilt After Cancer
January 27, 2021
ΚΑΡΚΙΝΟΣ ΣΤΟΜΑΧΟΥ
February 7, 2019
A new IARC live webinar on evidence in primary cancer prevention
November 11, 2021
Load more
HOT NEWS
FDA Approves Nivolumab and Ipilimumab for Unresectable Malignant Pleural Mesothelioma
Activity of Targeted/Immune Therapy Approach in Patients with Advanced Urothelial Cancer
Belzutifan Shows a Significant Benefit Over Everolimus in Patients with Advanced...
Rare Melanoma Very Likely to Respond to Treatment with Pembrolizumab
Ελληνικά
English (UK)
